Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Health
April 11, 2026 Evan Vega

Healthcare SEO Teams Choose DataForSEO for Privacy-Conscious Search Analytics

The SEO tools market is undergoing a fundamental shift. For over a decade, agencies and in-house teams have paid $99

Read More
CDC delays COVID report
Health
April 10, 2026 Evan Vega

CDC Delays Report on COVID-19 Vaccine Reducing ER Visits and Hospitalizations by Half

The CDC delayed a report showing the 2024–2025 COVID-19 vaccine reduced ER visits by 33% and hospitalizations by up to 46% in U.S. adults.

Read More
Zeaxanthin Enhances Cancer Immunotherapy
Health
April 10, 2026 Evan Vega

Zeaxanthin Nutrient from Vegetables Boosts T Cells and Cancer Immunotherapy Efficacy in New Study

A University of Chicago study found zeaxanthin enhances CD8+ T cell function and improves cancer immunotherapy efficacy in preclinical models.

Read More
Gut Bacteria Sugars Immune
Health
April 10, 2026 Evan Vega

Gut Bacteria Sugars Trigger Immune Attacks Linked to ALS and Frontotemporal Dementia

Case Western Reserve study finds gut bacteria sugars trigger immune attacks linked to ALS and frontotemporal dementia in C9orf72-deficient individuals.

Read More
Mississippi Health Chief Declines
Health
April 9, 2026 Evan Vega

Mississippi Health Chief Dan Edney Declines CDC Director Nomination

Mississippi State Health Officer Dr. Daniel P. Edney declined the nomination to become director of the CDC, officials confirmed Thursday.

Read More
Menthol Capsaicin Target Inflammation
Health
April 9, 2026 Evan Vega

Plant Compounds Like Menthol and Capsaicin Target Chronic Inflammation in Diabetes and Cancer

Studies show plant compounds like menthol and capsaicin reduce chronic inflammation in diabetes and cancer by targeting cellular pathways.

Read More
Hydrogen Sulfide Alzheimer's Target
Health
April 9, 2026 Evan Vega

Hydrogen Sulfide Gas from CSE Protein Emerges as Potential Alzheimer’s Treatment Target

Johns Hopkins researchers identify CSE enzyme and hydrogen sulfide as potential targets to prevent Tau protein-related Alzheimer’s progression.

Read More
Heroes Square monument in Budapest, Hungary ahead of the April 2026 parliamentary election
Health
April 9, 2026 Evan Vega

Russian Bots, Kremlin Agitprop, and Meta’s Blind Eye: The Disinformation War Over Hungary’s 2026 Election

As Hungary votes April 12, Russian GRU operatives, bot networks, and AI-generated deepfakes flood Facebook while Meta looks the other way. A comprehensive investigation into the Kremlin’s election interference machine and Zuckerberg’s complicity.

Read More
Oral Challenge Delabels Penicillin
Health
April 8, 2026 Evan Vega

Studies Confirm Direct Oral Challenge Safely Delabels Penicillin Allergies in Hospitals

Studies show direct oral challenge safely removes penicillin allergies in hospitals, increasing penicillin use 13-fold within 90 days.

Read More
Ozempic Wegovy cardiovascular reversal
Health
April 8, 2026 Evan Vega

Stopping Ozempic or Wegovy Reverses Cardiovascular Benefits, New Study Warns

A study finds stopping Ozempic or Wegovy for six months or more reverses cardiovascular benefits in type 2 diabetes patients.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.